Residency Program

Pharmacy

Residency Program

PGY2 Oncology

The pharmacy residency in oncology builds on experiences in the PGY1 year and is designed to provide a well-rounded experience leading to the development of expert knowledge, skills, and clinical leadership in the practice of oncology pharmacy. This 12-month program offers training opportunities through a variety of clinical rotations and interactions with multidisciplinary healthcare teams. We offer a flexible program that focuses on the goals of the resident and is intended to provide clinical, research, and teaching experience. Graduates of the program should be prepared to pursue employment as a hematology/oncology pharmacotherapy clinical specialist in the acute care setting, as well as demonstrate competency in written and oral communication, and oncology research.

The program emphasizes clinical practice with required rotations in leukemia, lymphoma, stem cell transplant, solid tumors, ambulatory oncology, investigational drug services, palliative care, and chemotherapy preparation. Elective rotations may be completed in any of the required rotations for an additional five weeks. Additional elective rotations include pediatric oncology and infectious diseases. Along with excellence in clinical care, NewYork-Presbyterian is committed to ongoing oncology research. Residents will have broad exposure to investigator-initiated research studies as well as ongoing Phase 1, 2, and 3 clinical trials in a wide range of malignancies.

Additional learning experiences include completion of a medication usage evaluation (MUE) and research project. Residents also participate in the Hematology/Oncology Subcommittee. The resident will develop teaching skills by providing in-service presentations to pharmacy staff and other health care providers, precepting PGY1 residents and pharmacy students, leading case-based clinical discussions, and critically evaluating literature.

This residency participates in the American Society of Health-System Pharmacists Residency Matching Program and is fully accredited by ASHP.

Required Rotations

  • Adult Leukemia (5 weeks)
  • Adult Lymphoma (5 weeks)
  • Adult Stem Cell Transplant (5 weeks)
  • Solid Tumor Outpatient Clinic (5 weeks)
  • Hematologic Malignancy Outpatient Clinic (5 weeks)
  • Inpatient Solid Tumors (5 weeks)
  • Investigational Drug Services (2 weeks)
  • Palliative Care (2 weeks)

Elective Rotations (2 electives, 5 weeks)

  • Pediatric Oncology (5 weeks)
  • Transplant Infectious Diseases (5 weeks)
  • Any required rotation may be repeated as an advanced elective

Compensation and Benefits

Residents earn an annual stipend of $53,000 Paid time off is allotted for vacation/personal time, holidays, interviews, and professional meetings. Additional benefits include travel stipend for professional meetings, comprehensive health insurance, and subsidized housing (pending availability).
This residency program participates in the American Society of Health-System Pharmacists (ASHP) Residency Matching Program and is fully-accredited by ASHP.

Staffing Coverage

PGY2 oncology pharmacy residents work on-site at the Weill Cornell Medical Center campus every third weekend. Residents provide clinical coverage on Saturdays and oncology pharmacy satellite coverage on Sundays. Duties may include, but are not limited to:

  • Pharmacy satellite operations
  • Drug information coverage
  • Chemotherapy admixture

To Apply

For more information on the requirements for submitting an application to our program, please visit our To Apply page.

OUR TEAM

Oncology


Peter-Cambell.jpg

Peter Cambell, PharmD, BCOP

Clinical Pharmacy Manager - Leukemia

Residency Program Director, PGY2 Oncology

Primary Campus: NewYork-Presbyterian Hospital / Columbia Irving Medical Center
Pharmacy Education: St John's University College of Pharmacy and Health Sciences
Post Graduate Training:
PGY1: NewYork-Presbyterian Hospital
PGY2 Oncology: NewYork-Presbyterian Hospital
Research/Professional Interests: Venous thromboembolism in oncology patients, Treatment and prevention of infections in neutropenic patients
[email protected]

Rachel-Abramova.jpg

Rachel Abramova, PharmD, BCOP

Clinical Pharmacy Manager - Bone Marrow Transplanation

Primary Campus: NewYork-Presbyterian Hospital / Columbia Irving Medical Center
Pharmacy Education: St John's University College of Pharmacy and Health Sciences
Post Graduate Training:
PGY1: NewYork-Presbyterian Hospital
PGY2 Oncology: NewYork-Presbyterian Hospital
Research/Professional Interests: GVHD and optimization of immunosuppression, infectious complications post-transplant, novel cellular therapies, academia
[email protected]

Syed-Arafath.jpg

Syed Arafath, PharmD, BCOP

Clinical Pharmacy Manager - Oncology

Primary Campus: NewYork-Presbyterian Hospital / Weill Cornell Medical Center
Pharmacy Education: Long Island University Arnold and Marie Schwartz College of Pharmacy
Post Graduate Training:
PGY1: The Johns Hopkins Hospital
PGY2 Oncology: NewYork-Presbyterian Hospital
Research/Professional Interests: Ambulatory oncology, gene editing, patient counseling, Informatics/AI in oncology
[email protected]

Lillian-Chou.jpg

Lillian Chou, PharmD, BCOP

Clinical Pharmacy Manager - Oncology

Primary Campus: NewYork-Presbyterian Hospital / Columbia Irving Medical Center
Pharmacy Education: Rutgers University Ernest Mario School of Pharmacy
Post Graduate Training:
PGY1: Grady Health System
PGY2 Oncology: The University of Texas MD Anderson Cancer Center
Research/Professional Interests: Quality Improvement; Chemotherapy/Antineoplastic Therapy Safety; Pharmacy Informatics
[email protected]

Ibis D. Lopez, PharmD, BCPS

Clinical Pharmacy Manager - Pediatric Oncology/Stem Cell Transplantation

Primary Campus: NewYork-Presbyterian Hospital / Morgan Stanley Children's Hospital
Pharmacy Education: Rutgers University Ernest Mario School of Pharmacy
Post Graduate Training:
PGY1: University of Kentucky
PGY2 Pediatrics: University of Kentucky/Kentucky Children’s Hospital
Research/Professional Interests: Pediatric leukemia and neuroblastoma; patient safety specifically chemotherapy; Pharmacy informatics regarding pediatrics and chemotherapy
[email protected]

Michelle-Nguyen.jpg

Michelle Nguyen, PharmD, BCOP

Clinical Pharmacy Manager - Oncology

Primary Campus: NewYork-Presbyterian Hospital / Columbia Irving Medical Center
Pharmacy Education: University of the Sciences - Philadelphia College of Pharmacy
Post Graduate Training:
PGY1: Paoli Hospital
PGY2 Oncology: Roswell Park Comprehensive Cancer Center
Research/Professional Interests: Immunotherapy, targeted therapy in solid tumors, pain management
[email protected]

Michelle-Pasciolla.jpg

Michelle Pasciolla, PharmD, BCOP

Clinical Pharmacy Manager - Bone Marrow Transplantation

Primary Campus: NewYork-Presbyterian Hospital / Weill Cornell Medical Center
Pharmacy Education: South Carolina College of Pharmacy
Post Graduate Training:
PGY1: NewYork-Presbyterian Hospital
PGY2 Oncology: NewYork-Presbyterian Hospital
Research/Professional Interests: Prevention of post-transplant complications and infections, immunosuppression, academia/preceptorship
[email protected]

Jennifer-Santamala.jpg

Jennifer Santamala, PharmD, BCOP

Clinical Pharmacy Manager - Lymphoma

Primary Campus: NewYork-Presbyterian Hospital / Weill Cornell Medical Center
Pharmacy Education: University of the Sciences - Philadelphia College of Pharmacy
Post Graduate Training:
PGY1: Lancaster General Hospital
PGY2 Oncology: NewYork-Presbyterian Hospital
Research/Professional Interests: CNS lymphoma/Immunotherapy/minimizing chemotherapy and optimizing targeted agents
[email protected]

Drew-Seidel.jpg

Drew Seidel, PharmD

Clinical Pharmacy Manager - Pediatric Oncology/Stem Cell Transplantation

Primary Campus: NewYork-Presbyterian Hospital / Morgan Stanley Children's Hospital
Pharmacy Education: St. John Fisher College, Wegmans School of Pharmacy
Post Graduate Training:
PGY1: University of Rochester Medical Center
PGY2 Pediatrics: University of Maryland School of Pharmacy/ University of Maryland Children’s Hospital
Research/Professional Interests: Risk stratification and treatment of pediatric ALL,  AML, targeted and cellular therapies, antimicrobial prophylaxis and management of infections in immunocomprimised patients, GVHD, CINV, medication safety, academia/precepting
[email protected]

Contact us

Call for an Appointment


NewYork-Presbyterian Hospital

Department of Pharmacy

Peter Campbell, PharmD, BCOP
Program Director, PGY2 Hematology/Oncology